Indian Court Blocks Sinopharm Weiqida Over Centrient's Amoxicillin

India’s High Court in Delhi has issued an injunction restraining China’s Sinopharm Weiqida from exporting, importing and selling its amoxicillin trihydrate in India, as it infringes Centrient’s patent. Sinopharm Weiqida has also been found guilty of contempt of court for failing to follow a preliminary injunction order that was issued in April 2017.

BrickWall
Sinopharm Weiqida has been blocked from selling amoxicillin in India • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin